Strengthening HPV Vaccination Equity Through Evidence Based Consultancy

The National Screening Service (NSS) and the National Immunisation Office (NIO) commissioned UCC researchers Dr Aoife O’ Mahony and Dr Sheena McHugh to deliver a rapid evidence review to inform strategies for improving HPV vaccination uptake among underserved populations, including migrant, Roma, and Traveller communities. The consultancy aimed to generate actionable insights within a tight timeframe to support national programme planning.

UCC Consulting was delighted to support Drs McHugh and O’Mahony with this undertaking. This involved assisting with the development of a detailed statement of work and negotiating contractual terms. Using rigorous rapid review methodology, the research team systematically searched peer reviewed literature across major databases. Evidence relating to barriers and enablers for HPV vaccination uptake was synthesised, enabling the NSS to understand capability, opportunity, and motivation-related drivers of vaccination uptake in these communities.

A second strand of work identified the types of intervention shown to enhance vaccine participation in comparable under-served populations internationally. These interventions were categorised using the Behaviour Change Wheel, helping decision makers identify the mechanisms, such as education, persuasion, and environmental restructuring most likely to influence behaviour. Where available, effectiveness data were also summarised.

The consultancy delivered two clear, accessible outputs: a comprehensive report with narrative synthesis and summary tables, and a plain language briefing for wider stakeholders. The NSS and NIO used these findings to inform the design of a pilot project comprising of consultation with communities on HPV vaccination and co-design of resources and outreach for HPV vaccination clinics. By translating complex evidence into practical, context-specific recommendations, the consultancy directly supported efforts to reduce health inequities, ensuring under-served communities are better reached by Ireland’s HPV vaccination programme.

This project was commissioned by the National Screening Service and the National Immunisation Office with Women’s Health Taskforce funding. 

This case study originally appeared in UCC's Innovation Impact Report for 2025, which can be read here .